This is unpublished

Cynthia E.

Infectious Diseases
Associate Professor, Department of Medicine, Division of Allergy & Infectious Diseases
Research Associate, Vaccine & Infectious Disease Division (VIDD), Fred Hutchison Cancer Researcher Center

related links


Dr. Fisher specializes in the research and treatment of infectious diseases in organ transplant recipients and cancer patients. Specific areas of investigation include risk factors, prevention, diagnosis, and treatment of invasive fungal infections and respiratory viral infections. She also focuses on identifying underlying genetic factors that predispose patients to develop severe infections following transplantation.

education & training

MPH, John Hopkins Bloomberg, School of Public Health, Baltimore MD (2006)

MD, John Hopkins Bloomberg, School of Public Health, Baltimore MD (2007)

Residency, University of Pennsylvania, Philadelphia, PA (2007-2010)

Fellowship in Infectious Diseases, University of Washington, Seattle WA (2010-2013)


Phi Beta Kappa (2001)

Merck Index Award, Top Chemistry/Biochemistry student at University of Washington (2002)

O.C. Hubert Fellow in International Health, Centers of Disease Control (2006)

Travel Grant, Infectious Disease Society of America (2012)



Seo S, Renaud C, Kuypers JM, Chiu CY, Huang M, Samayoa E, Xie H, Yu G, Fisher CE, Gooley T, et al. Idiopathic pneumonia syndrome after hematopoietic cell transplantation: Evidence of occult infectious etiologies. Blood. 2015 Jun 11; 125(24):3789-97.
PubMed Abstract

Preiksaitis CM, Kuypers JM, Fisher CE, Campbell AP, Jerome KR, Huang ML, Boeckh M, Limaye AP. A patient self-collection method for longitudinal monitoring of respiratory virus infection in solid organ transplant recipients. J Clin Virol. 2015; 62:98-102.
 PubMed Abstract 

Fisher CE, Stevens AM, Leisenring W, Pergam SA, Boeckh M, Hohl TM. Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis. Transplant Infect Dis. 2014 Jun; 16(3):505-10.
PubMed Abstract

Fisher CE, Stevens AM, Boeckh M, Leisenring W, Pergam S, Hohl T. Degree of positivity of serum galactomannan is associated with higher mortality in HCT patients with invasive aspergillosis. Clin Infect Dis. 2013 Oct 1; 57(7):1001–1004.
PubMed Abstract